Though whether EGFR mutation found in metastatic lymph nodes is accordance with that of the primary tumor is still unknown, however, molecular biological information provided by EBUS-TBNA is evidently of great value and maybe it can guide targeted therapy for advanced lung cancer patients. The gene discussed is EGFR; the disease is lung cancer.